Apogee Therapeutics, Inc. APGE Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s software and technology licenses, net?
- Apogee Therapeutics, Inc. (APGE) reported software and technology licenses, net of $8.52M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Apogee Therapeutics, Inc.'s software and technology licenses, net increased by 16.0% year-over-year, from $7.34M to $8.52M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s software and technology licenses, net has grown at a 365.0% compound annual growth rate (CAGR), from $401K to $8.67M.